Drug Shortage Report for ADREVIEW

Last updated on 2020-09-21 History
Report ID 124542
Drug Identification Number 02387034
Brand name ADREVIEW
Common or Proper name Iobenguane (123I) Injection
Company Name GE HEALTHCARE CANADA INC
Market Status MARKETED
Active Ingredient(s) IOBENGUANE 123 I
Strength(s) 74MBq
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5 mL
ATC code V09IX
ATC description
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-09-15
Estimated end date 2020-09-20
Actual end date 2020-09-20
Shortage status Resolved
Updated date 2020-09-21
Company comments
Health Canada comments
Contact Address 1919 MINNESOTA COURT
MISSISSAUGA, ONTARIO
CANADA L5N 0C9
Company contact information 800-387-7146 canadainfo@ge.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-09-21 French Compare
v3 2020-09-21 English Compare
v2 2020-09-18 French Compare
v1 2020-09-18 English Compare